Skip to main content

Advertisement

Log in

Letter to the editor regarding the article “pregnancy-associated breast cancer: a multicenter study comparing clinicopathological factors, diagnosis, and treatment outcomes with non-pregnant patients”

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Data availability

The datasets generated during and/or analysed during our original study are available from the corresponding author upon request.

References

  1. Tan QT, Alcantara VS, Sultana R, Loh KW, Go AL, Wong FY (2023) Pregnancy-associated breast cancer: a multicenter study comparing clinicopathological factors, diagnosis and treatment outcomes with non-pregnant patients. Breast Cancer Res Treat 198(1):53–66

    Article  PubMed  Google Scholar 

  2. Sajjadi E, Venetis K, Noale M, Azim HA Jr, Blundo C, Bonizzi G et al (2022) Breast cancer during pregnancy as a special type of early-onset breast cancer: analysis of the tumor immune microenvironment and risk profiles. Cells 11(15):2286

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Amant F, Lefrère H, Borges VF, Cardonick E, Lambertini M, Loibl S et al (2021) The definition of pregnancy-associated breast cancer is outdated and should no longer be used. Lancet Oncol 22(6):753–754

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was partially supported by the Italian Ministry of Health with Ricerca Corrente 5 x 1000 funds. The authors acknowledge support from the University of Milan through the APC initiative. Konstantinos Venetis was supported by Fondazione IEO – MONZINO.

Funding

This research received no external funding.

Author information

Authors and Affiliations

Authors

Contributions

ES wrote the initial version of the manuscript; NF supervised and revised the draft, which was edited by KV. All authors have read and agreed to the published version of the manuscript.

Corresponding author

Correspondence to Nicola Fusco.

Ethics declarations

Conflict of interest

N.F. has received honoraria for consulting, advisory role, speaker bureau, travel, and/or research grants from Merck Sharp & Dohme (MSD), Novartis, AstraZeneca, Roche, Daiichi Sankyo, GlaxoSmithKline (GSK), Gilead, Diaceutics, Adicet Bio, and Sermonix. These companies had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; and/or in the decision to publish the results. All other authors declare no potential conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sajjadi, E., Venetis, K. & Fusco, N. Letter to the editor regarding the article “pregnancy-associated breast cancer: a multicenter study comparing clinicopathological factors, diagnosis, and treatment outcomes with non-pregnant patients”. Breast Cancer Res Treat 199, 587–588 (2023). https://doi.org/10.1007/s10549-023-06951-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-023-06951-x

Navigation